Juliane K. Mueller

Heinrich Hoffmann Str. 10, 
Frankfurt Am Main, HE, DE 
Heinrich Hoffmann Str. 10, 
Frankfurt Am Main, HE, DE 

Overview

Juliane Mueller practices practicing medicine in Frankfurt Am Main, Germany.

Her clinical expertise encompasses Cyclothymic Disorder, Schizophrenia, Post-Traumatic Stress Disorder (PTSD), and Severe Acute Respiratory Syndrome (SARS).

She is actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Heinrich Hoffmann Str. 10, Frankfurt Am Main, HE 60528, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of Potential Central Glucoregulatory Compounds to Treat/Ameliorate the Symptoms of Schizophrenia: a Proof-of-concept Study in Healthy Volunteers.
Evaluation of Potential Central Glucoregulatory Compounds to Treat/Ameliorate the Symptoms of Schizophrenia: a Proof-of-concept Study in Healthy Volunteers.
Enrollment Status: Withdrawn
Publish Date: March 21, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients
A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients
Enrollment Status: Terminated
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Cannabidiol, Olanzapine
Study Phase: Phase 2
View 1 Less Clinical Trial

28 Total Publications

AURORA A interacts with DICER and SETD2 to promote S-phase progression.
AURORA A interacts with DICER and SETD2 to promote S-phase progression.
Journal: EMBO reports
Published: October 29, 2025

Frequently Asked Questions about Juliane K. Mueller

Is Juliane K. Mueller a top-rated expert for Cyclothymic Disorder?

MediFind is an objective health platform that identifies experts based on real-world data. Juliane K. Mueller is classified as an Experienced expert for Cyclothymic Disorder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Juliane K. Mueller participate in research or clinical trials?

Yes. Juliane K. Mueller has published 28 articles and abstracts on conditions like Cyclothymic Disorder. You can view a list of Juliane K. Mueller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mueller's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile